Implantable Cardiac Rhythm Management Device Market Size, Share & Trends Analysis Report By Product (Pacemaker, ICDs, CRT), By End-use (Hospitals, Specialty Cardiac Centers), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Implantable Cardiac Rhythm Management Devices Market Growth & Trends
The global implantable cardiac rhythm management devices market size is expected t%li%reach USD 15.53 billion by 2030, registering t%li%grow at a CAGR of 6.4% from 2024 t%li%2030 according t%li%a new report by Grand View Research, The increasing global geriatric population prone t%li%CVD diseases and the demand for accurate and effective diagnostics of these diseases are the factors contributing t%li%the growth of implantable cardiac rhythm management (CRM) devices.
Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Hectic schedules and busy lifestyles are major factors for hypertension among individuals. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Pacemakers are the most implanted devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.
The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued t%li%create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due t%li%a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due t%li%the pandemic.
Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Implanted pacemakers are majorly used for conduction disorders and sinus dysfunctions.
Implantable Cardiac Rhythm Management Devices Market Report Highlights
Implantable Cardiac Rhythm Management Devices Market Growth & Trends
The global implantable cardiac rhythm management devices market size is expected t%li%reach USD 15.53 billion by 2030, registering t%li%grow at a CAGR of 6.4% from 2024 t%li%2030 according t%li%a new report by Grand View Research, The increasing global geriatric population prone t%li%CVD diseases and the demand for accurate and effective diagnostics of these diseases are the factors contributing t%li%the growth of implantable cardiac rhythm management (CRM) devices.
Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Hectic schedules and busy lifestyles are major factors for hypertension among individuals. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Pacemakers are the most implanted devices for conduction disorders and sinus dysfunctions. CRT devices and ICDs are comparatively new and incorporate better technology than their older counterparts.
The COVID-19 pandemic adversely impacted the market, in particular the ICDs market, with dampened demand and sales during 2020. The sales improved as the hospitals resumed elective surgeries. However, the progression of COVID-19 in several key markets continued t%li%create uncertainty during the year. Abbott, for instance, reported improvement in its hospital-based businesses during Q2 and Q3 2020. However, the improving trends flattened or were negatively impacted during Q4 2020 due t%li%a sudden increase in COVID-19 cases and hospitalizations in many countries. Nihon Kohden, on the other hand, reported strong sales growth of defibrillators in 2020, despite inhibited sales activity due t%li%the pandemic.
Cardiac disorders are one of the major causes of mortality around the world, with a large percentage of the population suffering from some form of cardiac disorder in their lifetime. While the older population is at a higher risk, the prevalence of CVDs is increasing in the younger generation as well. Various implantable devices are being used for improved cardiac performance, including pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT) devices. Implanted pacemakers are majorly used for conduction disorders and sinus dysfunctions.
Implantable Cardiac Rhythm Management Devices Market Report Highlights
- The hospital's end-use segment captured the largest revenue share of over 68.9% in 2023. The growth can be attributed t%li%deeper product penetration, a large volume of surgical procedures, and rising patient footfall
- The ICDs product segment held the largest revenue share in 2023. The cardiac resynchronization therapy devices segment is expected t%li%register the fastest growth rate over the forecast period
- An estimated 85.7 million Americans (i.e., almost 34% of the population) suffered from high blood pressure and hypertension due t%li%stressful lifestyles. Almost 23.4 million American adults were diagnosed with diabetes in 2017, while an estimated additional 7.6 million American adults are undiagnosed diabetics. Globally, the prevalence of diabetes is expected t%li%increase t%li%7.7% in 2030
- The CRT product segment is anticipated t%li%register the fastest growth rate over the forecast period due t%li%the implementation of supportive legislative policies in developed countries and an increase in awareness and the number of training programs for use of the products
- North America dominated the market with a revenue share of over 47.6% in 2023. This can be attributed t%li%an increase in the incidence of cardiovascular diseases, supportive government policies, favorable reimbursement schemes, a rise in awareness, and an increase in the number of training programs
- Asia Pacific is expected t%li%exhibit the fastest CAGR during the forecast period due t%li%the higher prevalence of CVDs and rapidly aging population
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Segment
2.2.2. End-use Segment
2.2.3. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of arrhythmia disorders
3.2.1.2. Technological advancements in device functionality
3.2.1.3. Rising Heart failure (HF) cases
3.2.1.4. Growing geriatric population
3.2.1.5. Favorable reimbursement policies
3.2.2. Market restraint analysis
3.2.2.1. Stringent Regulatory Policies
3.3. Implantable Cardiac Rhythm Management Device Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Implantable Cardiac Rhythm Management Device Market: Product Dashboard
4.2. Implantable Cardiac Rhythm Management Device Market: Product Movement Analysis
4.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Pacemaker
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Conventional Pacemakers
4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. Leadless Pacemaker
4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. ICDs
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Single Chamber ICDs
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Dual Chamber ICDs
4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. CRT
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6.2. CRT-Defibrillator
4.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6.3. CRT-Pacemaker
4.6.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Implantable Cardiac Rhythm Management Device Market: End-use Dashboard
5.2. Implantable Cardiac Rhythm Management Device Market: End-use Movement Analysis
5.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Specialty Cardiac Centers
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY COUNTRY, PRODUCT, END-USE, & END-USE
6.1. Global Implantable Cardiac Rhythm Management Device Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Regulatory framework/ reimbursement structure
6.3.4.3. Competitive scenario
6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. End-use benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. End-use benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Boston Scientific Corporation
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. End-use benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Koninklijke Philips N.V.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. End-use benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Zoll Medical Corporation
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. End-use benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Biotronik
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. End-use benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Stryker
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. End-use benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Schiller AG
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. End-use benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Nihon Kohden Corporation
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. End-use benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Microport Scientific Corporation
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. End-use benchmarking
7.3.13.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. End-use
1.2.3. Regional scope
1.2.4. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity price analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product Segment
2.2.2. End-use Segment
2.2.3. Regional Outlook
2.3. Competitive Insights
CHAPTER 3. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of arrhythmia disorders
3.2.1.2. Technological advancements in device functionality
3.2.1.3. Rising Heart failure (HF) cases
3.2.1.4. Growing geriatric population
3.2.1.5. Favorable reimbursement policies
3.2.2. Market restraint analysis
3.2.2.1. Stringent Regulatory Policies
3.3. Implantable Cardiac Rhythm Management Device Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET: PRODUCT ESTIMATES & TREND ANALYSIS
4.1. Implantable Cardiac Rhythm Management Device Market: Product Dashboard
4.2. Implantable Cardiac Rhythm Management Device Market: Product Movement Analysis
4.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Pacemaker
4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.2. Conventional Pacemakers
4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.4.3. Leadless Pacemaker
4.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. ICDs
4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Single Chamber ICDs
4.5.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Dual Chamber ICDs
4.5.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. CRT
4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6.2. CRT-Defibrillator
4.6.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6.3. CRT-Pacemaker
4.6.3.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 5. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET: END-USE ESTIMATES & TREND ANALYSIS
5.1. Implantable Cardiac Rhythm Management Device Market: End-use Dashboard
5.2. Implantable Cardiac Rhythm Management Device Market: End-use Movement Analysis
5.3. Implantable Cardiac Rhythm Management Device Market Size & Forecasts and Trend Analysis, by End-use, 2018 to 2030 (USD Million)
5.4. Hospitals
5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Specialty Cardiac Centers
5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
CHAPTER 6. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICE MARKET: REGIONAL ESTIMATES & TREND ANALYSIS BY COUNTRY, PRODUCT, END-USE, & END-USE
6.1. Global Implantable Cardiac Rhythm Management Device Market: Regional Dashboard
6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
6.3. North America
6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamics
6.3.2.2. Regulatory framework/ reimbursement structure
6.3.2.3. Competitive scenario
6.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamics
6.3.3.2. Regulatory framework/ reimbursement structure
6.3.3.3. Competitive scenario
6.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamics
6.3.4.2. Regulatory framework/ reimbursement structure
6.3.4.3. Competitive scenario
6.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
6.4. Europe
6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.4.2. UK
6.4.2.1. Key country dynamics
6.4.2.2. Regulatory framework/ reimbursement structure
6.4.2.3. Competitive scenario
6.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
6.4.3. Germany
6.4.3.1. Key country dynamics
6.4.3.2. Regulatory framework/ reimbursement structure
6.4.3.3. Competitive scenario
6.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamics
6.4.4.2. Regulatory framework/ reimbursement structure
6.4.4.3. Competitive scenario
6.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamics
6.4.5.2. Regulatory framework/ reimbursement structure
6.4.5.3. Competitive scenario
6.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamics
6.4.6.2. Regulatory framework/ reimbursement structure
6.4.6.3. Competitive scenario
6.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
6.4.7. Sweden
6.4.7.1. Key country dynamics
6.4.7.2. Regulatory framework/ reimbursement structure
6.4.7.3. Competitive scenario
6.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
6.4.8. Norway
6.4.8.1. Key country dynamics
6.4.8.2. Regulatory framework/ reimbursement structure
6.4.8.3. Competitive scenario
6.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
6.4.9. Denmark
6.4.9.1. Key country dynamics
6.4.9.2. Regulatory framework/ reimbursement structure
6.4.9.3. Competitive scenario
6.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
6.5. Asia Pacific
6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. China
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
6.5.3. Japan
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
6.5.5. Australia
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
6.5.6. Thailand
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
6.5.7. South Korea
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
6.6. Latin America
6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
6.7. MEA
6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. Saudi Arabia
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
6.7.3. South Africa
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Manufacturers
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. End-use benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. End-use benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Boston Scientific Corporation
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. End-use benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Koninklijke Philips N.V.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. End-use benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Zoll Medical Corporation
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. End-use benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Biotronik
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. End-use benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Stryker
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. End-use benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Schiller AG
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. End-use benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Nihon Kohden Corporation
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. End-use benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Microport Scientific Corporation
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. End-use benchmarking
7.3.13.4. Strategic initiatives
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 4 Global implantable CRM devices market, by end-use, 2018 - 2030
Table 5 Global implantable CRM devices market, by region, 2018 - 2030 (USD Million)
Table 6 North America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 7 North America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 8 North America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 U.S. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 12 Canada implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 13 Mexico implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 14 Mexico implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 16 Europe implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 17 Europe implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 18 U.K. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 19 U.K. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Germany implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 21 Germany implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 France implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 23 France implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 24 Italy implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 25 Italy implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 26 Spain implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 27 Spain implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Denmark implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 29 Denmark implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 30 Sweden implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 31 Sweden implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 32 Norway implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 33 Norway implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific implantable CRM devices market, by Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 36 Asia Pacific implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 37 Japan implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 38 Japan implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 39 China implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 40 China implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 41 India implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 42 India implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 43 Australia implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 44 Australia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 45 Thailand implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 46 Thailand implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 47 South Korea implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 48 South Korea implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 49 Latin America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 51 Latin America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 52 Brazil implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 53 Brazil implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 54 Argentina implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 55 Argentina implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 56 MEA implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 57 MEA implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 58 MEA implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Africa implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 60 South Africa implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 63 UAE implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 64 UAE implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 65 Kuwait implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 66 Kuwait implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 67 Participant’s overview
Table 68 Financial performance
Table 69 Key companies undergoing expansions
Table 70 Key companies undergoing acquisitions
Table 71 Key companies undergoing collaborations
Table 72 Key companies launching new products/services
Table 73 Key companies undergoing partnerships
Table 74 Key companies undertaking other strategies
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 4 Global implantable CRM devices market, by end-use, 2018 - 2030
Table 5 Global implantable CRM devices market, by region, 2018 - 2030 (USD Million)
Table 6 North America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 7 North America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 8 North America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 9 U.S. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 12 Canada implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 13 Mexico implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 14 Mexico implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 15 Europe implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 16 Europe implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 17 Europe implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 18 U.K. implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 19 U.K. implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 20 Germany implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 21 Germany implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 22 France implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 23 France implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 24 Italy implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 25 Italy implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 26 Spain implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 27 Spain implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 28 Denmark implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 29 Denmark implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 30 Sweden implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 31 Sweden implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 32 Norway implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 33 Norway implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 34 Asia Pacific implantable CRM devices market, by Country, 2018 - 2030 (USD Million)
Table 35 Asia Pacific implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 36 Asia Pacific implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 37 Japan implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 38 Japan implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 39 China implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 40 China implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 41 India implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 42 India implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 43 Australia implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 44 Australia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 45 Thailand implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 46 Thailand implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 47 South Korea implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 48 South Korea implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 49 Latin America implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 50 Latin America implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 51 Latin America implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 52 Brazil implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 53 Brazil implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 54 Argentina implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 55 Argentina implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 56 MEA implantable CRM devices market, by country, 2018 - 2030 (USD Million)
Table 57 MEA implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 58 MEA implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Africa implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 60 South Africa implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 63 UAE implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 64 UAE implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 65 Kuwait implantable CRM devices market, by product, 2018 - 2030 (USD Million)
Table 66 Kuwait implantable CRM devices market, by end-use, 2018 - 2030 (USD Million)
Table 67 Participant’s overview
Table 68 Financial performance
Table 69 Key companies undergoing expansions
Table 70 Key companies undergoing acquisitions
Table 71 Key companies undergoing collaborations
Table 72 Key companies launching new products/services
Table 73 Key companies undergoing partnerships
Table 74 Key companies undertaking other strategies
LIST OF FIGURES
Fig. 1
LIST OF FIGURES
Fig. 2 eHealth Market Segmentation
Fig. 3 Information Procurement
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation and Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Market Snapshot
Fig. 8 Segment Snapshot (Part 1)
Fig. 9 Segment Snapshot (Part 2)
Fig. 10 Competitive Landscape Snapshot
Fig. 11 eHealth- Market Size and Growth Prospects (USD Billion)
Fig. 12 eHealth Market : Industry Value Chain Analysis
Fig. 13 eHealth Market : Market Dynamics
Fig. 14 eHealth Market : PORTER’s Analysis
Fig. 15 eHealth Market : PESTEL Analysis
Fig. 16 eHealth Market Share by product 2023 & 2030 (USD Billion)
Fig. 17 eHealth Market ,by product: Market Share, 2023 & 2030
Fig. 18 Telemedicine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 19 Health Information Systems Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 20 Electronic Health Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 21 Electronic Medical Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 22 Patient Engagement Solution Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 23 Population Health Management Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 24 mHealth Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 25 Monitoring services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 26 Diagnosis services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 27 Healthcare Systems Strengthening Services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 28 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 29 ePharmacy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 30 E-Prescribing Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 31 Computerized Physician Order Entry Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 32 eHealth Market, by End Use: Key Takeaways
Fig. 33 eHealth Market, by End Use: Market Share, 2023 & 2030
Fig. 34 Providers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 35 Payers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 36 Patients Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 37 Key Company Categorization
Fig. 38 Company Market Positioning
Fig. 39 Key Company Market Share Analysis, 2023
Fig. 40 Strategic Framework
Fig. 1
LIST OF FIGURES
Fig. 2 eHealth Market Segmentation
Fig. 3 Information Procurement
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation and Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Market Snapshot
Fig. 8 Segment Snapshot (Part 1)
Fig. 9 Segment Snapshot (Part 2)
Fig. 10 Competitive Landscape Snapshot
Fig. 11 eHealth- Market Size and Growth Prospects (USD Billion)
Fig. 12 eHealth Market : Industry Value Chain Analysis
Fig. 13 eHealth Market : Market Dynamics
Fig. 14 eHealth Market : PORTER’s Analysis
Fig. 15 eHealth Market : PESTEL Analysis
Fig. 16 eHealth Market Share by product 2023 & 2030 (USD Billion)
Fig. 17 eHealth Market ,by product: Market Share, 2023 & 2030
Fig. 18 Telemedicine Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 19 Health Information Systems Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 20 Electronic Health Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 21 Electronic Medical Record Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 22 Patient Engagement Solution Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 23 Population Health Management Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 24 mHealth Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 25 Monitoring services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 26 Diagnosis services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 27 Healthcare Systems Strengthening Services Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 28 Others Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 29 ePharmacy Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 30 E-Prescribing Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 31 Computerized Physician Order Entry Market Estimates & Forecasts, 2018 - 2030 (USD Million)
Fig. 32 eHealth Market, by End Use: Key Takeaways
Fig. 33 eHealth Market, by End Use: Market Share, 2023 & 2030
Fig. 34 Providers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 35 Payers Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 36 Patients Market Estimates & Forecasts, 2018 - 2030 (Revenue, USD Billion)
Fig. 37 Key Company Categorization
Fig. 38 Company Market Positioning
Fig. 39 Key Company Market Share Analysis, 2023
Fig. 40 Strategic Framework
